Hazardous Pharmacy Compounding Isolator: Top Questions Before You Buy The Isoclean® Healthcare Platform Isolator (HPI-G3)

Evaluating an isolator for hazardous drug preparation requires looking beyond basic brochure specifications. True operational fit depends on a comprehensive understanding of engineering logic, infrastructure constraints, and regional regulatory frameworks like USP <800>. One of the most critical initial decisions is selecting between total exhaust and recirculating airflow. For volatile antineoplastic agents, a total exhaust, single-pass ducted configuration is mandatory because mechanical HEPA filters cannot capture hazardous gas phases or vapors.

Integrating a ducted system demands precise HVAC alignment, requiring a facility-level evaluation of cubic meters per hour (CMH) and total static pressure resistance before equipment is specified. Furthermore, physical footprint planning must account for real-world accessories—such as pass-through chambers, stands, and anti-blowback valves—which add significantly to the base unit's dimensions.

Discover the essential engineering guidelines, physical clearance necessities, and validation phases required to build a compliant compounding environment. Read the full guide to seamlessly align your procurement with long-term facility strategy.